AI Article Synopsis

  • During World War I, many soldiers died from diseases like tetanus, and a special treatment called tetanus antiserum was used to help save lives.
  • A 100-year-old vial of this antiserum from the battlefield in France was studied to see if it still had any helpful antibodies.
  • The tests showed that while some proteins were still there, they couldn’t protect mice from tetanus, proving that even though the vials were old, the antibodies had lost their strength over time.

Article Abstract

During World War I (WWI), infectious diseases including tetanus were among the most important causes of death. Even though its efficacy was somewhat controversial before the war, tetanus antiserum played a key role in reducing the mortality of this disease. A vial of tetanus antiserum dating back from WWI, left behind on the French battlefield by the US Army, was borrowed from a private collection and opened. The serum contained within was characterized by orthogonal biochemical techniques to determine if any neutralizing IgGs could remain after 100 years of storage. In vitro analysis by Size Exclusion Chromatography and Serum Protein Electrophoresis suggested the presence of residual IgG. In spite of our hopes, these IgGs were not able to protect mice against tetanus toxin challenge in a neutralizing assay. Even though our results indicate the presence of remaining IgGs inside the serum, they were functionally disabled. These results show that obscurity alone is insufficient to protect IgGs from degradation over very long periods of time at room temperature. HIGHLIGHTS: Tetanus antiserum found its place in the therapeutic arsenal during World War I A century-old vial of tetanus antiserum was opened for biochemical and in vivo characterization Biochemical assays revealed the presence of proteins having all the characteristics of IgGs The serum was unable to protect mice against toxinic challenge.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12026-020-09121-zDOI Listing

Publication Analysis

Top Keywords

tetanus antiserum
16
vial tetanus
8
protect mice
8
iggs
6
tetanus
6
serum
5
history extensive
4
extensive characterization
4
characterization challenge
4
challenge anti-tetanus
4

Similar Publications

The quality of equine colostrum is typically defined by refractometry or the concentration of maternal antibodies. However, the activity of other equine colostral bioactive molecules has not yet been investigated. This study analyzed whether the administration of a fermentation product (SCFP) influences the biological activity of mare colostrum and whether the biological activity of colostrum has a lasting immunomodulating effect for foals.

View Article and Find Full Text PDF

Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge.

Vaccine

October 2024

Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address:

Immunity protective against shigella infection targets the bacterial O-specific polysaccharide (OSP) component of lipopolysaccharide. A multivalent shigella vaccine would ideally target the most common global Shigella species and serotypes such as Shigella flexneri 2a, S. flexneri 3a, S.

View Article and Find Full Text PDF

The use of the serum or plasma of patients or animals who have recovered from an infectious disease, or had been immunized with a relevant antigen, to treat or prevent the same infection in others began in the late 1880s when French and German scientists uncovered, one step at a time, several of the elements of the immune system's response to infection. A key finding was that the damage caused by some bacteria depends upon their secreted toxins which can be neutralized by biologic agents. Antitoxins to diphtheria and tetanus began to be manufactured in large animals in France, Germany, and the US in the 1890s and were soon being used worldwide.

View Article and Find Full Text PDF

Scorpion envenoming (SE) is a public health problem in developing countries. In Algeria, the population exposed to the risk of SE was estimated at 86.45% in 2019.

View Article and Find Full Text PDF
Article Synopsis
  • The study looked at snakebites in kids under 15 years old from a region in South China over almost 10 years.* -
  • Out of 69 kids, most got bitten on their legs, and nobody died; treatments included antivenom and antibiotics.* -
  • The researchers found patterns in the severity of bites and certain lab tests that could help predict how sick a child might get after a snakebite.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!